Altimmune Inc banner

Intrinsic Value

Is 3G0 undervalued or overvalued?

See the intrinsic value estimate for Altimmune Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

3G0 Intrinsic Value
LOCKED
Unlock
Today vs. history

3G0 looks undervalued.
But is it cheap by its own standards?

See how today’s valuation compares with 3G0’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor 3G0
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Intrinsic Value Locked
Current Price €2.55
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to 3G0

Fundamental Analysis

What Altimmune Does

Biotechnology Health Care

Altimmune is a clinical-stage biotechnology company that develops drugs for obesity, liver disease, and other serious conditions. It does not sell a finished medicine today; instead, it designs and tests experimental treatments in clinical trials, with a focus on peptide-based drugs and vaccine candidates.

Headquarters
United States of America US
Employees
57
IPO date
Oct 6, 2005
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Altimmune Inc

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Ownership

ALT Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one 3G0 stock?

The intrinsic value for Altimmune Inc (3G0) under the Base Case is hidden EUR.

Is 3G0 stock undervalued or overvalued?

Compared with the current market price of 2.545 EUR, the stock appears hidden.

Back to Top